Adherence and quality of life in women with breast cancer being treated with oral hormone therapy.
Purpose: To evaluate adherence to oral hormone therapy (HT) and which factors impact in incomplete adherence and quality of life.Methods: This was a cross-sectional study.Setting: Women's Hospital Prof. Dr. José Aristodemo Pinotti.Participants: women with breast cancer under treatment with oral HT.M...
| Publicado en: | Supportive Care in Cancer Vol. 27; no. 10; pp. 3799 - 3805 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Oct2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138431408&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 138431408 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09414355 O1J jtl: Supportive Care in Cancer issn: 09414355 maglogo: N pubinfo: dt: Oct2019 vid: 27 iid: 10 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 138431408 138431408 144155911 NLM30729297 138431408 10.1007/s00520-019-04671-x NLM30729297 138431408 ppf: 3799 ppct: 6 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Adherence and quality of life in women with breast cancer being treated with oral hormone therapy. aug: au: Stahlschmidt, Rebeca Ferracini, Amanda Canato de Souza, Cinthia Madeira de Medeiros, Luana Moreira Juliato, Cassia Raquel Teatin Mazzola, Priscila Gava affil: Faculty of Medical Sciences, University of Campinas (Unicamp), Tessália Vieira de Camargo Street, 126, Cidade Universitária "Zeferino Vaz", 13083-887, Campinas, SP, Brazil sug: subj: Antineoplastic Agents, Hormonal Therapeutic Use Aromatase Inhibitors Therapeutic Use Tamoxifen Therapeutic Use Breast Neoplasms Drug Therapy Quality of Life Psychosocial Factors Middle Age Cross Sectional Studies Female Breast Neoplasms Psychosocial Factors Ferrans and Powers Quality of Life Index Impact of Events Scale Human Funding Source Middle Aged: 45-64 years Female ab: Purpose: To evaluate adherence to oral hormone therapy (HT) and which factors impact in incomplete adherence and quality of life.Methods: This was a cross-sectional study.Setting: Women's Hospital Prof. Dr. José Aristodemo Pinotti.Participants: women with breast cancer under treatment with oral HT.Main Outcome Measures: interview and performed an adherence questionnaire (Morisky-Green) and two questionnaires of quality of life (EORTC-QLQ30/BR23). The interviews were done once in a 5-month period.Results: Fifty-eight women were interviewed: 42 under treatment with tamoxifen (TX) and 16 under treatment with aromatase inhibitor (AI). Twenty-six women (44%) showed high adherence to the treatment, 31 (54%) medium adherence, and 1 (2%) low adherence. Statistical analysis showed a relation between incomplete adherence and systemic therapy side effects as well as higher stages of disease, with no difference between the two drugs. When treatments were compared, this study showed treatment with AI presented less breast symptoms and better role functioning. Quality of life score was high, compared to the reference value.Conclusions: A low percentage of women with breast cancer were highly adherent to HT treatment. Low/medium adherence was associated with higher stages of disease and systemic side effects. Quality of life had high scores, with better role function and less breast symptoms in women being treated with an AI. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|